Logo image of ABNX.PA

ABIONYX PHARMA SA (ABNX.PA) Stock Analyst Ratings

Europe - Euronext Paris - EPA:ABNX - FR0012616852 - Common Stock

3.865 EUR
+0.13 (+3.34%)
Last: 1/22/2026, 5:10:50 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to ABNX.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 10.71. This target is 177.1% above the current price.
  • ABNX.PA was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ABNX.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • ABNX.PA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

ABNX.PA Historical Analyst RatingsABNX.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -109 -99 -89 -79 -69 -59 -49 -39 -29 -19 -9 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 3.8710.1010.7110.7111.55 - 161.32% 177.10% 177.10% 198.84%

Related screens

ABNX.PA Current Analyst RatingABNX.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

ABIONYX PHARMA SA / ABNX.PA FAQ

What is the average price target for ABIONYX PHARMA SA (ABNX.PA) stock?

8 analysts have analysed ABNX.PA and the average price target is 10.71 EUR. This implies a price increase of 177.1% is expected in the next year compared to the current price of 3.865.


What is the consensus rating for ABNX stock?

The consensus rating for ABIONYX PHARMA SA (ABNX.PA) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover ABIONYX PHARMA SA (ABNX.PA) stock?

The number of analysts covering ABIONYX PHARMA SA (ABNX.PA) is 8.